Navigation Links
Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
Date:7/23/2009

ing for diluted earnings per share is higher than for basic earnings per share due to the assumed conversion of the Company's outstanding convertible senior debentures, outstanding stock options, deferred contingent common stock awards, performance share awards, restricted stock awards and convertible preferred stock into common stock equivalents using the treasury stock method. For purposes of calculating diluted earnings per share, interest expense, net of capitalized interest and taxes related to the Company's outstanding convertible senior debentures, is added back to reported net income, and the additional shares of common stock (assuming conversion) are included in total shares outstanding. Interest expense, net of capitalized interest and taxes related to these debentures, was $2,485 and $5,440 for the 2009 second quarter and first half, respectively, compared with $6,765 and $13,836 for the 2008 second quarter and first half, respectively. Pursuant to the right of the holders to require the Company to repurchase their convertible senior debentures, on July 15, 2009, the Company announced the repurchase of $765,139, or 97.1% of the outstanding principal amount of these debentures. In addition, the Company redeemed all of its outstanding shares of convertible preferred stock on July 15, 2009.
  • Other (income) expense, net included net hedging income for the 2009 second quarter and first half of $64,812 and $139,098, respectively, compared with net hedging expense of $45,257 and $71,906 for the 2008 second quarter and first half, respectively. Other (income) expense, net also included royalty income for the 2009 second quarter and first half of $144,942 and $178,564, respectively, compared with $112,231 and $167,989 for the 2008 second quarter and first half, respectively. The 2009 second quarter and first half included a one-time royalty receipt of $108,500. The 2008 second quarter and first half included a one-time royalty milestone receipt
    '/>"/>

  • SOURCE Wyeth
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine news :

    1. Wyeth Announces Results of the Companys Offer Relating to Holder Right to Surrender Convertible Debentures
    2. Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated For Women and Men
    3. Wyeths Prevenar 13* Receives First Approval
    4. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
    5. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
    6. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
    7. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
    8. DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza
    9. Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
    10. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
    11. Wyeth Reports Earnings Results for the 2009 First Quarter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
    (Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
    (Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
    (Date:12/25/2014)... 26, 2014 Recently, Dylan Queen, a ... excitedly released its collection of discounted prom dresses, most ... a senior spokesman of the company, the promotion is ... promotion is to expand the UK market. , The ... different colors, lengths, and styles: A-line strapless, empire strapless ...
    (Date:12/25/2014)... Los Angeles, CA (PRWEB) December 25, 2014 ... Blaise Dolcemaschio was created in honor of a true ... premiere at two film festivals including the 24 hours of ... Film Festival in Bangladesh. , Actress, screenwriter and ... and helped produce this film together with her husband, ...
    Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
    ... Kabi Pty Ltd, one of Australia,s fastest growing and ... (Robotic IV Automation) - a self-contained unit for filling ... (IH Systems) to consolidate its IV preparation. Pharmatel Fresenius ... in June 2009. , The RIVA System and Pharmatel ...
    ... Feb. 11 Naturs Design, Inc., a privately held ... the revolutionary product that virtually eliminates all of the ... for sleep apnea. Unfortunately, CPAP therapy hasn,t always been ... reports that "many CPAP users never continue therapy beyond ...
    ... Gynecologic Oncologists, 40th Annual Meeting on Women,s Cancer Proves ... Pa., Feb. 11 New data presented on Saturday ... Oncologists, 40th Annual Meeting on Women,s Cancer demonstrated the ... CA125 blood test results and the Risk of Ovarian ...
    ... 11 Rising Medical Solutions, Inc. (Rising), ... management organization, announced today that it has ... Accreditation from URAC, a Washington, DC-based health ... quality standards for the health care industry.(Logo: ...
    ... announced today that Laurence Debroux is ... (CSO).In light of the implementation of the Group,s ... the position of Chief Strategic Officer at the ... business development and acquisition activities as well as ...
    ... Feb. 11 The Quantum Group, Inc. ( NYSE ... that Pete Martinez, Senior Vice President and Chief Technology ... the St. Thomas University Healthcare Seminar later ... Economic Times." Martinez will contribute to the event ...
    Cached Medicine News:Health News:Australia's Leading Oncology Drug Compounder Chooses RIVA System 2Health News:Husband From Small Town May Have Found Solution to Sleep Industry's 20-Year Compliance Problem 2Health News:Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer 2Health News:Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer 3Health News:Rising Medical Solutions Receives URAC Workers' Compensation Utilization Management Accreditation 2Health News:Rising Medical Solutions Receives URAC Workers' Compensation Utilization Management Accreditation 3Health News:Laurence Debroux Appointed Chief Strategic Officer (CSO) 2Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 2Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 3Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 4
    (Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... is being recalled after Health Canada tests confirmed it ... health risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health ... recalling the product from retail stores across ... building purposes, including for weight loss and increased energy. ...
    (Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
    (Date:12/24/2014)... -- Actavis plc (NYSE: ACT ) today ... response letter from the U.S. Food and Drug ... for the fixed-dose combination (FDC) of nebivolol and ... Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... a complete response letter, Actavis remains committed to ...
    Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
    ... Corporation (NYSE: SYK ) reported operating results for ... Third Quarter Highlights Net sales ... to $1,768 million Orthopaedic Implants sales increased 1.3% on ... Equipment sales increased 16.3% on a constant currency basis (16.1% ...
    ... Calif., Oct. 19 ThermoGenesis Corp. (Nasdaq: ... services that process and store adult stem cells, said ... agreement for its Res-Q™ 60 BMC (Res-Q) System with ... point-of-care cardiovascular therapies. Under the agreement, ...
    Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 2ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 3
    For children up to 4 years of age 11 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
    ... capture and management system that acquires extremely ... Angiography images. It interfaces with most current ... from any ophthalmic device with video, digital ... the features of EyeCap RI, with further ...
    The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
    ... mirrored surfaces, which each incline at an ... have been cut into the 17 mm ... to examine the opposite iridocorneal angle without ... form of the angle of the iris ...
    Medicine Products: